Bai Jia Bin, Shakerian Rezvaneh, Westcott James David, Lichtenstein Meir, Miller Julie A
Department of Surgery, University of Melbourne, Parkville, Victoria, Australia.
Department of Surgery, Royal Melbourne Hospital, Parkville, Victoria, Australia.
ANZ J Surg. 2015 Jul-Aug;85(7-8):572-7. doi: 10.1111/ans.12368. Epub 2013 Aug 22.
Total thyroidectomy followed by radioactive iodine (RAI) ablation is indicated for most patients with differentiated thyroid cancer. There have been no quantitative studies testing factors that affect uptake on post-ablation whole body scan. We hypothesized greater RAI uptake in patients who underwent two-stage total thyroidectomy (diagnostic hemithyroidectomy followed by completion thyroidectomy) compared to patients who underwent one-stage total thyroidectomy.
Medical records and whole body scan images of thyroid cancer patients were reviewed. Thyroid uptake as a percentage of Iodine-131 dose was calculated for each scan. RAI uptake was compared to procedure type, central lymph node dissection (CLND), extrathyroidal invasion, presence of thyroiditis and pre-operative diagnosis.
One hundred six patients who underwent total thyroidectomy and RAI ablation for differentiated thyroid cancer were included. There was a trend to higher RAI uptake in patients who had undergone two-stage thyroidectomy compared to one-stage thyroidectomy (P = 0.06). CLND was associated significantly lower RAI uptake (P = 0.003). On multivariate analyses, CLND was the only variable that retained statistical significance (P = 0.023). CLND was performed more often in patients undergoing one-stage thyroidectomy (P = 0.001), as these patients' cancer diagnosis was known prior to surgery.
RAI uptake appeared higher in two-stage thyroidectomy than one-stage thyroidectomy. This difference may be attributed to CLND being performed more often in one-stage thyroidectomy. These results add to the discussion about the role of CLND in surgery for differentiated thyroid cancer.
对于大多数分化型甲状腺癌患者,全甲状腺切除术后进行放射性碘(RAI)消融是必要的。目前尚无定量研究来检验影响消融后全身扫描摄取情况的因素。我们推测,与接受一期全甲状腺切除术的患者相比,接受两期全甲状腺切除术(诊断性甲状腺半切术,随后进行甲状腺全切术)的患者有更高的RAI摄取率。
回顾甲状腺癌患者的病历和全身扫描图像。计算每次扫描中甲状腺摄取碘-131剂量的百分比。将RAI摄取情况与手术方式、中央淋巴结清扫术(CLND)、甲状腺外侵犯、甲状腺炎的存在以及术前诊断进行比较。
纳入了106例接受全甲状腺切除术及RAI消融治疗的分化型甲状腺癌患者。与一期甲状腺切除术相比,接受两期甲状腺切除术的患者有RAI摄取率更高的趋势(P = 0.06)。CLND与显著更低的RAI摄取率相关(P = 0.003)。在多变量分析中,CLND是唯一具有统计学意义的变量(P = 0.023)。CLND在接受一期甲状腺切除术的患者中更常进行(P = 0.001),因为这些患者在手术前癌症诊断已明确。
两期甲状腺切除术的RAI摄取率似乎高于一期甲状腺切除术。这种差异可能归因于CLND在一期甲状腺切除术中更常进行。这些结果为关于CLND在分化型甲状腺癌手术中的作用的讨论增添了内容。